Table 3

Therapy associated autoantibodies in 62 initially negative patients

	Induction during months 0–3 of therapy	Induction during follow up period	Induction throughout observation period, in total
GAD65-Abs^3-150	1	4^3-160	5^3-160
IA2-Abs	1	–	1
21OH-Abs	2	1	3
TG-Abs	3	9	12
TPO-Abs	–	4	4

↵3-150 Results of the ³⁵S assay.
↵3-160 Only one patient tested positive by the ¹²⁵I assay.
Abs, autoantibodies; GAD65, glutamic acid decarboxylase; IA2, protein tyrosine phosphatase; 21OH, 21-hydroxylase; TG, thyroglobulin; TPO, thyroid peroxidase.